<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9806">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05689762</url>
  </required_header>
  <id_info>
    <org_study_id>Varberga</org_study_id>
    <nct_id>NCT05689762</nct_id>
  </id_info>
  <brief_title>Promotion of Healthy Lifestyle Habits in a Primary Care Setting</brief_title>
  <official_title>Promotion of Healthy Lifestyle Habits in a Primary Care Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Örebro University, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Örebro University, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intervention aiming to promote healthy dietary and physical activity behaviors in adults with&#xD;
      low socio-economic position in a primary health care setting&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 10, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood glucose</measure>
    <time_frame>Before ; at 16 weeks; at 24 months</time_frame>
    <description>Blood glucose (mmol/L) assessed using chemistry kits from Ortho-Clinical Diagnostics on a Vitros-5.1 analyzer platform (Clinical Diagnostics, Raritan, NJ, United States)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in plasma triglycerides</measure>
    <time_frame>Before ; at 16 weeks; at 24 months</time_frame>
    <description>Plasma triglycerides (mmol/L) : assessed using chemistry kits from Ortho-Clinical Diagnostics on a Vitros-5.1 analyzer platform (Clinical Diagnostics, Raritan, NJ, United States)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in waist circumference</measure>
    <time_frame>Before ; at 16 weeks; at 24 months</time_frame>
    <description>waist circumference (cm) assessed by a steel tape</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy Lifestyle</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Healthy lifestyle</intervention_name>
    <description>Promotion of healthy lifestyle behaviors</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age, high metabolic risk- poor lifestyle habits (diet and physical activity)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  overt disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fawzi Kadi, professor</last_name>
    <phone>+4619302160</phone>
    <email>fawzi.kadi@oru.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Örebro University</name>
      <address>
        <city>Örebro</city>
        <zip>70182</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>fawzi Kadi, Phd</last_name>
      <phone>019302160</phone>
      <phone_ext>0046</phone_ext>
      <email>fawzi.kadi@oru.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>December 23, 2022</study_first_submitted>
  <study_first_submitted_qc>January 10, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2023</study_first_posted>
  <last_update_submitted>January 24, 2023</last_update_submitted>
  <last_update_submitted_qc>January 24, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

